Dechra Pharmaceuticals PLC — Director's Dealing 2014

Oct 14, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2670U

Dechra Pharmaceuticals PLC

14 October 2014

14 October 2014

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

Director / PDMR Shareholding 

Grant of SAYE options:

Dechra Pharmaceuticals PLC announces that yesterday the following Directors and PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the Options).

The Options have been granted with an exercise price of £6.14.

Name	Capacity	Options Granted
Ian Page	Director	1,465
Anne-Francoise Nesmes	Director	1,465
Zoe Goulding	PDMR	2,052

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQKQDPBBDDBKD